ACA
CRSP icon

Atlas Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,600
Closed -$121K 923
2021
Q4
$121K Hold
1,600
0.02% 425
2021
Q3
$179K Sell
1,600
-1,600
-50% -$179K 0.03% 357
2021
Q2
$518K Buy
+3,200
New +$518K 0.09% 199